About the Company
We do not have any company description for DYADIC INTERNATIONAL INC at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on DYADIC INTERNATIONAL INC
Dyadic International Inc (DYAI) Q2 2025 Earnings Call Highlights: Strategic Shifts and Market ...
Dyadic International Inc (DYAI) transitions to a revenue-driven model with promising market opportunities, despite facing financial hurdles and increased competition.
Dyadic International, Inc. (NASDAQ:DYAI) Q2 2025 Earnings Call Transcript
August 13, 2025Dyadic International, Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. Operator: Good evening, and welcome to Dyadic International's ...
What to Expect from Dyadic International Inc (DYAI) Q2 2025 Earnings
Dyadic International Inc (NASDAQ:DYAI) is set to release its Q2 2025 earnings on Aug 13, 2025. The consensus estimate for Q2 ...
Dyadic International, Inc. to Announce First Quarter 2025 ... - Nasdaq
Dyadic International, Inc. announced that it will release its financial results for the first quarter of 2025 and hold a corporate update conference call on May 14, 2025, at 5:00 p.m. Eastern Time.
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.
Dyadic International, Inc. CEO to Present at 2025 World Vaccine ...
Dyadic International, Inc., a biotechnology company specializing in microbial production platforms for large-scale protein manufacturing, announced that CEO Mark Emalfarb will present at the 2025 ...
Dyadic International Announces Fully Funded Human Health R&D ...
CONTACT: Dyadic International, Inc. Ping W. Rawson Chief Financial Officer Phone: (561) 743-8333 Email: mailto:prawson@dyadic.com SOURCE: Dyadic International, Inc.
Dyadic International, Inc. and Proliant Health and Biologicals announce ...
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health ...
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.
Dyadic International, Inc. Announces Pricing of Public Offering of ...
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock Provided by GlobeNewswire Jul 31, 2025, 4:30:00 AM ...
Dyadic International, Inc. Announces Research and Development ...
JUPITER, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 ...
Dyadic International, Inc. (DYAI) Q1 2025 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ:DYAI) Q1 2025 Earnings Conference Call May 14, 2025 5:00 PM ETCompany ParticipantsPing Rawson - Chief Financial ...
Similar Companies
Loading the latest forecasts...